Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Ofatumumab for Early Relapsing-Remitting Multiple Sclerosis
Recruiting3 awardsPhase 4
Pensacola, Florida
This trial will study the effects of ofatumumab in people with RRMS who are in the early stages of the disease. The study will use clinical and MRI outcomes to track changes in the disease, as well as digital devices, biomarkers, and non-conventional MRI. The results of the ofatumumab group will be compared to a group of healthy people to see if there are any similarities between the two groups after treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.